Effects of Tadalafil on Platelets and Endothelium in Patients With Erectile Dysfunction and Cardiovascular Risk Factors: A Pilot Study

Abstract

Activation of endothelial cells and platelets is an initial step toward the development of cardiovascular disease. Erectile dysfunction (ED) may be an early manifestation of endotheliopathy. We evaluated the effects of tadalafil on cyclic nucleotides (cGMP and cAMP) and soluble adhesion molecules (E- and P-selectin [ES and PS]). The patients were divided into 2 groups on the basis of the presence (10 patients) or absence (9 patients) of cardiovascular risk factors (dyslipidemia, hypertension, and smoking). Nitric oxide (NO) was unmeasurable in all the patients. Tadalafil administration induced a significant increase in cGMP levels in both groups (P < .01). In contrast, cAMP significantly increased (P < .05) and PS decreased (P < .01) only in patients without cardiovascular risk factors. Tadalafil induced a beneficial effect on platelet activation in patients with ED without cardiovascular risk factors; this effect was not mediated by NO.

Keywords

tadalafil P-selectin cyclic nucleotide erectile dysfunction cardiovascular risk factors

Get full access to this article

View all access options for this article.

References

Davı G. , Patrono C. Platelet activation and atherothrombosis . N Eng J Med. 2007;357(24):2482-2494.

Ross R. Atherosclerosis-an inflammatory disease. N Eng J Med. 1999;340(24):115-126.

Vane JR , Anggard EE , Botting RM Regulatory functions of the vascular endothelium. N Engl J Med. 1990;323(1):27-36.

Haller H. Endothelial Function. Drugs. 1997;53(suppl 1):1-10.

Behrendt D. , Ganz P. Endothelial function: from vascular biology to clinical applications . Am J Cardiol. 2002;90(suppl): 40L-48L.

Loscalzo J. Nitric oxide, platelet activation, and arterial thrombosis. Circ Res. 2001;88(8):756-762.

Anderson TJ Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction . Heart Fail Rev. 2003; 8(1):71-86.

Harrison DG Cellular and molecular mechanism of endothelial cell dysfunction. J Clin Invest. 1997;100(9):2153-2157.

Walford G. , Loscalzo J. Nitric oxide in vascular biology. J Thromb Haemost . 2003;1(10):2112-2118.

10.

Azuma H. , Ishikawa M. , Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol. 1986;88(2):411-415.

11.

Rao GH , Krishnamurthi S. , Raij L. , White JG Influence of nitric oxide on agonist-mediated calcium mobilization in platelets . Biochem Med Metab Biol. 1990 ;43(3):271-275.

12.

Cerra MC , Pellegrino D. Cardiovascular cGMP-generating systems in physiological and pathological conditions . Curr Med Chem. 2007;14(5):585-599.

13.

Omori K. , Kotera J. Overview of PDEs and their regulation. Circ Res. 2007;100(3):309-327.

14.

Bender AT , Beavo JA Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use . Pharmacol Rev. 2006; 58(3):488-520.

15.

Ahluwalia A. , Foster P. , Scotland RS , et al. Anti-inflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment. Proc Natl Acad Sci U S A. 2004;101(5):1386-1391.

16.

Blann AD , Lip GYH. Hypothesis: is soluble P-selectin a new marker of platelet activation ? Atherosclerosis. 1997;128(2):135-138.

17.

Cella G. , Vianello F. , Cozzi F. , et al. Effect of bosentan on plasma markers of endothelial cell activity in patients with secondary pulmonary hypertension related to connective tissue disease. J Rheumatol. 2009;36(4):665-666.

18.

Fijnheer R. , Frijns CJM , Korteweg J. , et al. The origin of P-selectin as a circulating plasma protein. Thromb Haemost. 1997;77(6): 1081-1085.

19.

Kyrle PA , Hron G. , Eichinger S. , Wagner O. Circulating P-selectin and the risk of recurrent venous thromboembolism . Thromb Haemost. 2007;97(6):880-883.

20.

Ikeda H. , Takajo Y. , Ichiki K. , et al. Increased soluble form of P-selectin in patients with unstable angina. Circulation. 1995; 92(7):1693-1696.

21.

Tsakiris DA , Tschopl M. , Jager K. , et al. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease. Atherosclerosis . 1999;142(1):193-200.

22.

Laumann EO , Paik A. , Rosen RC Sexual dysfunction in the United States: prevalent and predictors . JAMA. 1999;281(6):537-544.

23.

Guay AT ED2: erectile dysfunction = endothelial dysfunction. Endocrinol Metab Clin N Am. 2007;36(2):453-463.

24.

Printzker M. The penile stress test: a window to the hearts of man? Circulation. 1999;100(suppl 1):350-353.

25.

Van Gils JM , Zwaginga JJ , Hordijk PL Molecular and functional Interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leuk Biol. 2009;85(2):1-9.

26.

Libby P. , Ridker PM , Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135-1143.

27.

Frenette PS , Johnson RC , Hynes RO , Wagner DD Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci U S A. 1995 ;92(16): 7450-7454.

28.

Gawaz M. , Langer H. , May AE Platelets in inflammation and atherosclerosis. J Clin Invest . 2005;115(12):3378-3384.

29.

Bocchio M. , Desideri G. , Scarpelli P. , et al. Endothelial cell activation in men with erectile dysfunction without cardiovascular risk factors and overt vascular damage. J Urol. 2004;171(4): 1601-1604.

30.

Bivalacqua TJ , Hellstrom WJG , Kadowitz PJ , Champion HC Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Biochem Biophys Res Commun. 2001;283(4):923-927.

31.

Jeremy JY , Angelini GD , Khan M. , et al. Platelets, oxidant stress and erectile dysfunction: a hypothesis . Cardiovasc Res. 2000; 46(1):50-56.

32.

Andrews NP , Husain M. , Dakak N. , Quyyumi AA Platelet inhibitory effect of nitric oxide in the human coronary circulation: impact of endothelial dysfunction. J Am Coll Cardiol. 2001; 37(2):510-516.

33.

Münzel T. , Daiber A. , Ullrich V. , Mülsch A. Vascular consequence of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMPdependent protein kinase. Arterioscler Thromb Vasc Biol. 2005 ; 25(8):1551-1557.

34.

Anfossi G. , Russo I. , Massucco P. , et al. Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: possible role in platelet hyperactivation in obesity. Eur J Clin Invest. 2004;34(7):482-489.